MedTrace Logo

PRomoting Older Adults' Pneumococcal Vaccination Through Education and Learning

NCT06234683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 720

Last updated 2025-04-30

No results posted yet for this study

Summary

The goal of this trial is to compare the effect of a web-based educational video about pneumococcal vaccines and a reminder email to get vaccinated (intervention) with a reminder email alone (comparator) in adults aged 65 or older living in any Canadian province who reported not having received a pneumococcal vaccine.

The main questions this trial aims to answer are:

1. does the educational intervention improve pneumococcal vaccine uptake,
2. does the educational intervention improve willingness to be vaccinated,
3. does the educational intervention improve knowledge of pneumococcal vaccination,
4. and does the educational intervention improve attitudes towards pneumococcal vaccines/vaccination?

Eligible participants who provide electronic consent will:

1. fill out a web-based baseline survey,
2. receive access to the educational video (if assigned to the intervention group),
3. receive an email reminder to be vaccinated (both groups),
4. and fill in a web-based follow-up survey.

Conditions

  • Pneumococcal Vaccine Uptake
  • Vaccination Willingness
  • Pneumococcal Vaccine Knowledge
  • Pneumococcal Vaccine Attitude

Interventions

OTHER

Web-based educational video on pneumococcal vaccination

Participants will receive a link to view a short video on pneumococcal vaccination.

OTHER

Reminder email to be vaccinated

Participants will receive a reminder email to be vaccinated.

Sponsors & Collaborators

  • University of Ottawa

    lead OTHER

Principal Investigators

  • Giorgia Sulis, PhD · School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-06
Primary Completion
2024-12-12
Completion
2024-12-12

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06234683 on ClinicalTrials.gov